U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6552165521A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical PalliationRecruitingNo Results AvailableHypoplastic Left Heart Syndromehttps://ClinicalTrials.gov/show/NCT01708863
6552265522Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)RecruitingNo Results AvailableNeoplasm|Central Venous Catheter ThrombosisDrug: Rivaroxabanhttps://ClinicalTrials.gov/show/NCT01708850
6552365523Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive DysfunctionActive, not recruitingNo Results AvailableCognition DisordersDrug: Propofolhttps://ClinicalTrials.gov/show/NCT01708837
6552465524Diet and Physical Activity Intervention in CRC SurvivorsActive, not recruitingNo Results AvailableColorectal CancerBehavioral: Dietary|Behavioral: Physical activityhttps://ClinicalTrials.gov/show/NCT01708824
6552565525Hyponatremia and Myometrium Contractility. An Invitro StudyRecruitingNo Results AvailableHyponatremiahttps://ClinicalTrials.gov/show/NCT01708811
6552665526Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast CancerRecruitingNo Results AvailableBreast CancerDrug: Eplerenonehttps://ClinicalTrials.gov/show/NCT01708798
6552765527Learning Theory to Improve Obesity TreatmentRecruitingNo Results AvailableObesityBehavioral: 8 treatment sessions|Behavioral: Cue exposure treatment (clinical trial)|Behavioral: Family-based Behavioral Treatment (FBT)|Behavioral: 16 treatment sessions|Behavioral: Single foods|Behavioral: Multiple foods|Behavioral: Daily sessions|Behavioral: Weekly sessions|Behavioral: Partial reinforcement - Yes|Behavioral: Partial reinforcement - No|Behavioral: Single context|Behavioral: Multiple contextshttps://ClinicalTrials.gov/show/NCT01708785
6552865528Serum TNF-a in Comparison to Sequential Organ Failure Assessment (SOFA) Score Monitoring in Critically Ill PatientsCompletedNo Results AvailableSepsis|Critically Illhttps://ClinicalTrials.gov/show/NCT01708772
6552965529IL8 Monitoring and Its Correlation With 251-gene PolymorphismCompletedNo Results AvailableSepsis|Systemic Inflammatory Response Syndromehttps://ClinicalTrials.gov/show/NCT01708759
6553065530Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's ViewsCompletedNo Results AvailableHigh Risk Pregnancyhttps://ClinicalTrials.gov/show/NCT01708746
6553165531The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver FunctionCompletedNo Results AvailableLiver FunctionDrug: KSYhttps://ClinicalTrials.gov/show/NCT01708733
6553265532Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy AdultsCompletedNo Results AvailablePoliomyelitisDrug: IPV|Drug: Sabin-IPV|Drug: Adjuvanted Sabin-IPVhttps://ClinicalTrials.gov/show/NCT01708720
6553365533Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)Enrolling by invitationNo Results AvailableNeonatal Abstinence Syndrome|Neonatal Withdrawal SyndromeDrug: Buprenorphine|Drug: Morphine Sulfatehttps://ClinicalTrials.gov/show/NCT01708707
6553465534Role of Slowly Digesible Starch on Diabetes Risk Factors(STARCH)RecruitingNo Results AvailablePrediabetesDietary Supplement: Amylose|Dietary Supplement: Amylopectinhttps://ClinicalTrials.gov/show/NCT01708694
6553565535Lean Seafood Intake and Postprandial MetabolismActive, not recruitingNo Results AvailableHyperlipidemias|Nutritional and Metabolic Diseases|Nutrition Disorders|Metabolic Diseases|Glucose Metabolism DisordersDietary Supplement: Lean seafood|Dietary Supplement: Meat, egg, milkhttps://ClinicalTrials.gov/show/NCT01708681
6553665536The Effects of Intermittent Epidural Bolus on Fever During Labor AnalgesiaRecruitingNo Results AvailableLabor Pain|Pain|Neurologic Manifestations|Signs and Symptoms|Pathological Conditions, Signs and SymptomsProcedure: Epidural analgesia|Procedure: Combined spinal-epidural analgesia|Procedure: Continuous epidural infusion|Procedure: Intermittent epidural bolushttps://ClinicalTrials.gov/show/NCT01708668
6553765537Sweat Evaporimeter MeasurementCompletedNo Results AvailableCystic FibrosisOther: Sweat Evaporimeter measurementhttps://ClinicalTrials.gov/show/NCT01708655
6553865538The Effect of Administration of Low Dose Adrenaline During Surgery on Bleeding During Hip SurgeryCompletedNo Results AvailableIntraoperative Blood LossDrug: Adrenaline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01708642
6553965539Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis SubjectsTerminatedNo Results AvailableModerate to Severe Plaque PsoriasisDrug: 210 mg brodalumab|Drug: 140 mg brodalumab|Drug: ustekinumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT01708629
6554065540A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteerDrug: RO5285119|Drug: RO5285119 placebo|Drug: risperidone|Drug: risperidone placebohttps://ClinicalTrials.gov/show/NCT01708616
6554165541Study of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis SubjectsTerminatedNo Results AvailableModerate to Severe Plaque PsoriasisDrug: 210 mg brodalumab|Drug: 140 mg brodalumab|Drug: ustekinumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT01708603
6554265542Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis SubjectsTerminatedNo Results AvailableModerate to Severe Plaque PsoriasisDrug: 210 mg brodalumab|Drug: 140 mg brodalumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT01708590
6554365543UMIC Validation StudyCompletedNo Results AvailableHealthyDevice: Validation of the IPANEMA - measurement systemhttps://ClinicalTrials.gov/show/NCT01708577
6554465544A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or BCompletedNo Results AvailableHemophiliaBiological: rhFVIIahttps://ClinicalTrials.gov/show/NCT01708564
6554565545Histological Analysis Following Ulthera System Treatment for HyperhidrosisActive, not recruitingNo Results AvailableHyperhidrosisDevice: Ulthera System Treatmenthttps://ClinicalTrials.gov/show/NCT01708551
6554665546The Effects of Corneal Collagen Cross-linkingRecruitingNo Results AvailableCorneal Ectasia Disorders Including KeratoconusDrug: CXLhttps://ClinicalTrials.gov/show/NCT01708538
6554765547Feasibility Study: Heavy Water Tissue Labeling ProtocolCompletedHas ResultsSkin LaxityDevice: Ulthera® System Treatment|Other: Heavy Waterhttps://ClinicalTrials.gov/show/NCT01708525
6554865548Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and NeckCompletedNo Results AvailableSkin LaxityDevice: Ulthera System Treatmenthttps://ClinicalTrials.gov/show/NCT01708512
6554965549Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal TissueCompletedNo Results AvailableSkin Laxity|Skin CrepinessDevice: Ulthera System Treatmenthttps://ClinicalTrials.gov/show/NCT01708499
6555065550BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) StudyCompletedNo Results AvailableAsthmahttps://ClinicalTrials.gov/show/NCT01708486

* Görseller ve İçerik tekif hakkına sahip olabilir